WCM-Q Grand Rounds 'Male Infertility: From Basic Science to Clinical Management'

RSS

Add to Calendar WCM-Q Grand Rounds 'Male Infertility: From Basic Science to Clinical Management' 11/22/2026 3:30:00 PM 11/22/2026 4:30:00 PM Asia/Riyadh For More Details: https://wcmq.cloud-cme.com/course/courseoverview?EID=4737 Description: Activity Code: API-02-P278Date:Sunday, November 22, 2026Speaker:KareimKhalafallaMD, CABU,FECSMLearning Objectives:At the end of this activity participants will be able to:Classify the causes of male infertility according to anatomic level (pre-testicular, testicular, post-testicular).Interpret semen analysis parameters according to current WHO reference values.Differentiate obstructive from non-obstructi... Livestreamed (Zoom) false MM/DD/YYYY


Date & Location
Sunday, November 22, 2026, 3:30 PM - 4:30 PM, Livestreamed (Zoom)

Overview

Activity Code: API-02-P278

Date: Sunday, November 22, 2026

Speaker: Kareim Khalafalla MD, CABU, FECSM

Learning Objectives:

At the end of this activity participants will be able to:

  1. Classify the causes of male infertility according to anatomic level (pre-testicular, testicular, post-testicular).

  2. Interpret semen analysis parameters according to current WHO reference values.

  3. Differentiate obstructive from non-obstructive causes of azoospermia.

  4. Formulate an appropriate management plan based on the diagnostic evaluation.

To be able to register for the activity, you MUST first Sign In to the portal.

The registration closes ONE day before the activity. You will receive a UNIQUE link to join the webinar on the day of the presentation.


Target Audience
Specialties - Allied Health Professionals, Dentists, Nurses, Pharmacists, Physicians, Students

Overall Learning Objective
  1. Classify the causes of male infertility according to anatomic level (pre-testicular, testicular, post-testicular).
  2. Interpret semen analysis parameters according to current WHO reference values.
  3. Differentiate obstructive from non-obstructive causes of azoospermia.
  4. Formulate an appropriate management plan based on the diagnostic evaluation.

Registration
No Registration Fee

Accreditation

DHP 

This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health's Department of Healthcare Professions-Accreditation Section and is approved for a maximum of 1.00 hour.

The scientific planning committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators and/or authors in advance of this CPD activity and has implemented procedures to manage any potential or real conflicts of interest.


ACCME

Weill Cornell Medicine-Qatar is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Weill Cornell Medicine-Qatar designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Disclosure of Relationships/Content Validity

It is the policy of Weill Cornell Medicine-Qatar to adhere to Department of Healthcare Professions (DHP) and Accreditation Council for Continuing Medical Education (ACCME) Criteria, Policies, and Standards for Commercial Support and content validation in order to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored programs. All faculty participating in sponsored programs are expected to disclose relevant financial relationships pertaining to their contribution to the activity, and any discussions of off-label or investigational uses of approved commercial products or devices, or of any products or devices not yet approved in the United States and elsewhere. WCM-Q CME/CPD activities are intended to be evidence-based and free of commercial bias. 

Scientific Planning Committee: Tariq Chukir, MD, Thurayya Arayssi, MD, Sohaila Cheema, MBBS, Deema Al-Sheikhly, MRes, MEPH, Andrew Jones, BSN, Phyllis Sui Muffuh Navti, Doctorate in Pharmacy Practice, Reshma Bholah, MD, Constatina Dalassou, DDS, Devin Thompson, RT, Leena Amine, PharmD, Mahrukh Rizvi, MD, have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

Jamie M. Gray, MLS, has disclosed the following relationships: Stocks or Stock Options, excluding diversified mutual funds - Proctor & Gamble, Colgate-Palmolive and Intuitive Surgical Inc, Crisper Therapeutics, Dexcom.

 All of the relevant financial/non-financial relationships with any for-profit/not-for-profit organizations have been mitigated; WILL NOT BE DISCUSSING any unlabelled/unapproved use of drugs or products.

Faculty: Kareim Khalafalla MD, CABU, FECSM, has no relevant financial/non-financial relationships with any for-profit /not-for-profit organizations to disclose and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products. 


Administrative Contacts: Asha Fernandes, Safia Rabia, have no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.

ICR: Tariq Chukir, MD, has no relevant financial/non-financial relationships with any for-profit/not-for-profit organizations to disclose and WILL NOT BE DISCUSSING any unlabeled/unapproved use of drugs or products.


Additional Information

Recording, Transcription, and AI Tools

This educational activity is intended solely for registered participants. Except as expressly authorized by the organizers, participants may not record, photograph, reproduce, transcribe, summarize, distribute, or otherwise capture any portion of the activity, including through the use of artificial intelligence (AI) tools, automated notetaking applications, transcription services, or similar technologies.

Participants are expected to comply with all activity instructions and applicable institutional policies regarding recording and use of AI tools. The organizers reserve the right to take appropriate action in the event of unauthorized recording, transcription, or distribution of activity content including the removal of unauthorized AI bots or automated meeting assistants.

If an official recording is prepared by the organizers and made available to registered participants after the activity it will be for personal use only, and may not be shared, distributed, or further reproduced.

 

 Attendance and Credit Eligibility

 CE/CPD credit is awarded based on verified individual participation in the educational activity. Participants must register and join the activity under their own name and remain personally present for the duration required to receive credit.Where use of an AI bot, automated notetaking assistant, or similar tool has been expressly authorized, such authorization does not permit the tool to attend the activity in place of the registered participant. The presence of an automated tool does not, by itself, constitute attendance or participation by the registered participant for purposes of CE/CPD credit.

Where the organizers are unable to verify the registered participant’s attendance and participation in accordance with applicable CE/CPD requirements, credit will not be awarded.